Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,054 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[The utility of the Pneumonia PORT prediction rule for evaluating the severity of community-acquired pneumonia in Japan. The relationship between disease severity and drug-resistant Streptococcus pneumoniae].
Nishiyama O, Taniguchi H, Kondoh Y, Kimura M, Shimizu J. Nishiyama O, et al. Among authors: shimizu j. Kansenshogaku Zasshi. 2002 Dec;76(12):1003-9. doi: 10.11150/kansenshogakuzasshi1970.76.1003. Kansenshogaku Zasshi. 2002. PMID: 12607346 Japanese.
A multicenter phase II study of carboplatin and paclitaxel for advanced thymic carcinoma: WJOG4207L.
Hirai F, Yamanaka T, Taguchi K, Daga H, Ono A, Tanaka K, Kogure Y, Shimizu J, Kimura T, Fukuoka J, Iwamoto Y, Sasaki H, Takeda K, Seto T, Ichinose Y, Nakagawa K, Nakanishi Y; West Japan Oncology Group. Hirai F, et al. Among authors: shimizu j. Ann Oncol. 2015 Feb;26(2):363-8. doi: 10.1093/annonc/mdu541. Epub 2014 Nov 17. Ann Oncol. 2015. PMID: 25403584 Free article. Clinical Trial.
Propensity score-weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non-small cell lung cancer (WJOG10217L).
Kato R, Hayashi H, Chiba Y, Miyawaki E, Shimizu J, Ozaki T, Fujimoto D, Toyozawa R, Nakamura A, Kozuki T, Tanaka K, Teraoka S, Usui K, Nishino K, Hataji O, Ota K, Ebi N, Saeki S, Akazawa Y, Okuno M, Yamamoto N, Nakagawa K. Kato R, et al. Among authors: shimizu j. J Immunother Cancer. 2020 Feb;8(1):e000350. doi: 10.1136/jitc-2019-000350. J Immunother Cancer. 2020. PMID: 32066647 Free PMC article.
Gefitinib for the treatment of non-small-cell lung cancer.
Hida T, Ogawa S, Park JC, Park JY, Shimizu J, Horio Y, Yoshida K. Hida T, et al. Among authors: shimizu j. Expert Rev Anticancer Ther. 2009 Jan;9(1):17-35. doi: 10.1586/14737140.9.1.17. Expert Rev Anticancer Ther. 2009. PMID: 19105704 Review.
Salvage surgery for small cell lung cancer after chemoradiotherapy.
Nakanishi K, Mizuno T, Sakakura N, Kuroda H, Shimizu J, Hida T, Yatabe Y, Sakao Y. Nakanishi K, et al. Among authors: shimizu j. Jpn J Clin Oncol. 2019 Apr 1;49(4):389-392. doi: 10.1093/jjco/hyz010. Jpn J Clin Oncol. 2019. PMID: 30753585
1,054 results